Seven Springs Wealth Group, LLC Gilead Sciences, Inc. Transaction History
Seven Springs Wealth Group, LLC
- $273 Million
- Q1 2025
A detailed history of Seven Springs Wealth Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Seven Springs Wealth Group, LLC holds 3,362 shares of GILD stock, worth $349,042. This represents 0.14% of its overall portfolio holdings.
Number of Shares
3,362
Previous 2,816
19.39%
Holding current value
$349,042
Previous $260,000
44.62%
% of portfolio
0.14%
Previous 0.1%
Shares
9 transactions
Others Institutions Holding GILD
# of Institutions
2,247Shares Held
998MCall Options Held
8.86MPut Options Held
8.69M-
Black Rock Inc. New York, NY121MShares$12.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.2 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.18 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.67 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.56 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $130B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...